Abstract:Bruno Bordoni, 1 Allan Escher, 2 Elena Compalati, 1 Luca Mapelli, 1 Anastasia Toccafondi 1 1 Department of Cardiology, Institute of Hospitalization and Care with Scientific Address, Foundation Don Carlo Gnocchi IRCCS S Maria Nascente, Milano, Italy; 2 Anesthesiology/Pain Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Correspondence: Bruno Bordoni, Email Chronic obstructive pulmonary disease (COPD) is a constant and chronic narrowing of the respiratory airways, with numerous associated symptoms, not always related to the pathological adaptation of the lungs. Statistical projections show that COPD could become the third leading cause of death globally by 2030, with a significant increase in deaths by 2060. Skeletal muscle dysfunction, including the diaphragm, is one of the causes linked to the increase in mortality and hospitalization. Little emphasis is given by the scientific literature to the importance of the diaphragm towards functional neuromotor pathological expressions. The article reviews the adaptation of the skeletal muscles, with greater attention to the adaptations of the diaphragm, thereby highlighting the non-physiological variations that the main respiratory muscle undergoes and the neuromotor impairment found in COPD. The text could be an important reflection from a clinical and rehabilitation point of view, to direct greater attention to the function and adaptation of the diaphragm muscle. Keywords: diaphragm, COPD, physiotherapy, rehabilitation, pain, fascia, ageing, osteopathic Chronic obstructive pulmonary disease (COPD) is a complex and constantly evolving pathology, which is characterized by a progressive and constant limitation of the available air volume (airflow obstruction). 1 COPD could become the third leading cause of death for the population by 2030. 1 The Global Initiative for Chronic Obstructive Lung Disease (GOLD) identifies COPD as: a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. 2 GOLD estimates that the number of patients who will die of COPD in 2060 will be approximately 5.4 million deaths annually, compared to 3.2 million deaths in 2015 annually. 3 In the USA, the incidence of the disease involves 10.2–20.9% of the population, in Europe, despite a trend of reduction in mortality and a decreased difference between men and women, the percentage of findings remains high (3–26.1%). 3 Some data from Africa, few and not covering all geographical areas, show COPD detection rates of 1.6–23.8%; in Latin America, the percentage is between 30% and 31.1%. 3 In China, the percentage is about 8.6% (data from 2018), and highly variable and incomplete values for other Asian regions, with an average of 3.5–6.7%. 3 COPD is considered as the fifth cause of burden on the economy of the various states due to recurring hospitalizations and pharmacological treatments. 4 Probably, this global economic aggravation derives from the fact that this pathology does not involve only the pulmonary area but develops many dysfunctions and physiological alterations involving the whole-body system. 4 Although emphysema and chronic bronchitis are responsible for triggering the chronicity of the disease, the patient does not always go to hospital for respiratory reasons, but for important cardiac problems, fractures, the onset of lung tumours, mood disorders, muscle complex that prevent independence and severe metabolic alterations. 1,5 Furthermore, it is not always possible to correctly assess the severity of COPD, as there is only a moderate relationship between pulmonary adaptation and the reduction in the patient's quality of life. 6 COPD is a systemic disease, and as such it is expressed with multiple symptoms, such as insomnia and drowsiness, dry mouth, anorexia, pain (local or from multiple involved areas), nausea, constipation, gastric reflux, dysphagia, sleep apnea, cough, fatigue and shortness of breath, wheezing and dyspnea, temporomandibular disorders and urinary incontinence. 2,5,7–10 Some symptoms related to the presence of COPD and which have a negative impact on the mortality and morbidity of patients, are the finding of anxiety and depression, with values ranging from 8% up to a maximum of 80% of patients. 1,5,11 Functional and structural alterations of the skeletal muscles (almost all patients), lack of coordination and an increase in accidental falls cause a decrease in active movement, leading to a decline in quality of life, an increase in mortality and in -Abstract Truncated-

Diaphragmatic surface EMG and COPD Inflammatory profile

Relationship between Chronic Obstructive Pulmonary Disease Severity and Surface Electromyography Parameters during Fatigue Caused by Knee Extensor Contractions

Correlation between diaphragm thickness and respiratory synergist muscle activity according to severity of chronic obstructive pulmonary disease

Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD

The Importance of the Diaphragm in Neuromotor Function in the Patient with Chronic Obstructive Pulmonary Disease

Ultrasonographic evaluation of diaphragmatic thickness and movement for assessment of diaphragmatic dysfunction in COPD patients

Differences of ventilatory muscle recruitment and work of breathing in COPD and interstitial lung disease during exercise: a comprehensive evaluation

Is the Power Spectrum of Electromyography Signal a Feasible Tool to Estimate Muscle Fiber Composition in Patients with COPD?

Study of the diaphragm in chronic obstructive pulmonary disease using ultrasonography

Diaphragmatic mobility: relationship with lung function, respiratory muscle strength, dyspnea, and physical activity in daily life in patients with COPD

Ultrasound Evaluation of the Quadriceps Muscle Contractile Index in Patients with Stable Chronic Obstructive Pulmonary Disease: Relationships with Clinical Symptoms, Disease Severity and Diaphragm Contractility

Ultrasonography as a way of evaluating the diaphragm muscle in patients with chronic obstructive pulmonary disease

COPD is accompanied by co-ordinated transcriptional perturbation in the quadriceps affecting the mitochondria and extracellular matrix

Surface electromyography signal processing and evaluation on respiratory muscles of critically ill patients: A systematic review

Air trapping: The major factor limiting diaphragm mobility in chronic obstructive pulmonary disease patients

Alterations of Plasma Inflammatory Biomarkers in the Healthy and Chronic Obstructive Pulmonary Disease Patients with or Without Acute Exacerbation.

Ultrasound Evaluation of Diaphragm Force Reserve in Patients with Chronic Obstructive Pulmonary Disease

Inspiratory muscle dysfunction mediates and predicts a disease continuum of hypercapnic failure in chronic obstructive pulmonary disease

Examination of diaphragm thickness, mobility and thickening fraction in individuals with COPD of different severity

Respiratory muscle function and activation in chronic obstructive pulmonary disease